Latest News
Alcester, UK. 1 October 2018. Quanta Dialysis Technologies Ltd (“Quanta”), a medical device company pioneering innovative haemodialysis products for dialysis patients, is pleased to announce that it has won the “Industrial Product Design of the Year” […]
Ireland and USA. 14 Sept 2018. Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round […]
Dublin, Ireland. 7 Sept 2018. TG plc (LSE:BTG) (BTG) and Seroba’s portfolio company, Novate, today announced the signing of a definitive agreement in which BTG has acquired Novate for a $20m upfront payment with additional potential […]
California, USA. 17 July, 2018. Labcyte Inc., today announced an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination of efforts for the Genome Project-write […]
Milpitas, California. 28 June 2018. Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long blockages in the superficial femoral artery (SFA). […]
Alcester, UK. 25 April 2018. Seroba’s investee company Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions, has announced that it has successfully completed a clinical pilot to treat […]
Oss, The Netherlands & Dublin, Ireland. 16 March 2018. H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under […]
Little Rock, Arkansas. 2 March 2018. Seroba’s investee company, PQ Bypass was making eye-catching headlines in the USA this week. Arkansas Heart Hospital is the first U.S. hospital to perform the DETOUR procedure and the story […]
- « Previous
- 1
- …
- 10
- 11
- 12